We need your support to keep TheyWorkForYou running and make sure people across the UK can continue to hold their elected representatives to account.

Donate to our crowdfunder

Idiopathic Pulmonary Fibrosis

Department of Health written question – answered on 7th November 2014.

Alert me about debates like this

Photo of Gregory Campbell Gregory Campbell DUP, East Londonderry

To ask the Secretary of State for Health, what steps his Department has taken to act upon the research by the National Institute for Health Research into idiopathic pulmonary fibrosis.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

The Department’s National Institute for Health Research (NIHR) is funding a systematic review of evidence on the benefits, harms and costs of treatments for idiopathic pulmonary fibrosis (IPF). The report is expected to be published in the journal Health Technology Assessment in January 2015.

The NIHR Clinical Research Network (CRN) provides support to help the life sciences industry set up and deliver large multi-centre clinical trials in the National Health Service, across a wide range of disease and therapeutic areas. The CRN is currently hosting trials assessing the efficacy and safety of lebrikizumab and simtuzumab in patients with IPF. The CRN is also recruiting patients to a pilot study seeking to test whether omeprazole can reduce cough in patients with IPF.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.